Efficacy of Seven-day Combined Rabeprazole Plus Levofloxacin Plus Augmentin for Eradication of Helicobacter Pylori

• Status: Terminated
• Trial end date: 2009-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This prospective controlled randomized open-label clinical trial is designed to determine the eradication rate of 7-day levofloxacin, amoxicillin/clavulanate and rabeprazole regimen compared with 7-day standard triple therapy for adults infected with Helicobacter pylori in Eastern Taiwan.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Buddhist Tzu Chi General Hospital
• Treatments: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Clarithromycin; Clavulanic Acid; Clavulanic Acids; Levofloxacin; Ofloxacin; Rabeprazole

Criteria

Inclusion Criteria:

• Patient proved with infection of H. pylori in gastric mucosa

• Patient with signed informed consent.

Exclusion Criteria:

• woman in breast feeding or pregnancy.

• allergy or severe adverse effects to drugs used in study.

• severe complications of peptic ulcer disease (like perforation or obstruction).

• patients with history of cancer or failure of major organs.